SecSonar.com

Compugen Ltd. (CGEN)

Compugen Ltd. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Compugen Ltd. (CGEN) is a Biotechnology company based in IL with a market capitalization of $254.8M. Revenue grew 161.1% year-over-year and the company generated $31.3M in free cash flow. This page tracks CGEN's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

IL · 74 employees · IPO Aug 11, 2000

Valuation

Valuation & price

$2.65 · as of May 26, 2026 · -14.4% vs 52w high

7.0

P/E ratio

Latest-FY diluted EPS

2.48

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$3.10$2.22$1.34Jul 25Dec 25Jul 26Jul 7, 25$1.72Jul 9, 25$1.67Jul 11, 25$1.59Jul 15, 25$1.58Jul 17, 25$1.59Jul 21, 25$1.51Jul 23, 25$1.57Jul 25, 25$1.53Jul 29, 25$1.48Jul 31, 25$1.45Aug 4, 25$1.46Aug 6, 25$1.46Aug 11, 25$1.50Aug 13, 25$1.48Aug 15, 25$1.43Aug 19, 25$1.46Aug 21, 25$1.43Aug 25, 25$1.43Aug 27, 25$1.47Aug 29, 25$1.41Sep 3, 25$1.42Sep 5, 25$1.43Sep 9, 25$1.43Sep 11, 25$1.40Sep 16, 25$1.38Sep 18, 25$1.34Sep 22, 25$1.43Sep 24, 25$1.40Sep 26, 25$1.38Sep 30, 25$1.47Oct 2, 25$1.76Oct 6, 25$1.79Oct 8, 25$1.81Oct 10, 25$1.85Oct 14, 25$2.11Oct 16, 25$1.95Oct 21, 25$1.76Oct 23, 25$1.67Oct 27, 25$1.71Oct 29, 25$1.65Oct 31, 25$1.77Nov 4, 25$1.61Nov 6, 25$1.64Nov 10, 25$1.67Nov 12, 25$1.68Nov 14, 25$1.64Nov 18, 25$1.62Nov 20, 25$1.52Nov 25, 25$1.59Nov 28, 25$1.56Dec 2, 25$1.51Dec 4, 25$1.61Dec 8, 25$1.55Dec 10, 25$1.63Dec 12, 25$1.53Dec 16, 25$1.49Dec 18, 25$1.51Dec 22, 25$1.53Dec 24, 25$1.54Dec 29, 25$1.47Jan 2, 26$1.55Jan 6, 26$1.55Jan 8, 26$1.64Jan 12, 26$1.98Jan 14, 26$1.98Jan 16, 26$2.36Jan 21, 26$2.11Jan 23, 26$2.09Jan 27, 26$2.02Jan 29, 26$1.93Feb 2, 26$1.81Feb 4, 26$1.74Feb 9, 26$1.71Feb 11, 26$1.71Feb 13, 26$1.65Feb 18, 26$1.70Feb 20, 26$1.74Feb 24, 26$1.77Feb 26, 26$1.79Mar 2, 26$2.25Mar 4, 26$2.14Mar 6, 26$2.08Mar 10, 26$2.24Mar 12, 26$2.21Mar 17, 26$2.27Mar 19, 26$2.11Mar 23, 26$2.09Mar 25, 26$2.06Mar 27, 26$2.04Mar 31, 26$2.13Apr 2, 26$2.26Apr 7, 26$2.32Apr 9, 26$2.48Apr 13, 26$2.76Apr 15, 26$2.89Apr 17, 26$2.82Apr 22, 26$2.83Apr 24, 26$3.10Apr 28, 26$2.73Apr 30, 26$2.66May 4, 26$2.64May 6, 26$2.76May 8, 26$2.90May 12, 26$2.83May 14, 26$3.03May 18, 26$2.86May 20, 26$2.71May 22, 26$2.80May 28, 26$2.78Jun 1, 26$2.46Jun 3, 26$2.19Jun 5, 26$2.10Jun 9, 26$2.02Jun 11, 26$2.04Jun 15, 26$2.02Jun 17, 26$1.99Jun 22, 26$2.07Jun 24, 26$2.01Jun 26, 26$2.09Jul 2, 26$2.28
$1.3352-week range$3.10
Loading valuation history…

Fundamentals

Key fundamentals

$254.8M

Market cap

161.1%

Revenue growth (YoY)

87.3%

Gross margin

$31.3M

Free cash flow (USD)

-$142.7M

Net debt

Net cash position

4.3%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$712.0KFY 2017$0.00FY 2018$17.8MFY 2019$0.00FY 2020$2.0MFY 2021$6.0MFY 2022$7.5MFY 2023$33.5MFY 2024$27.9MFY 2025$72.8M
$712K$72.8M

Free cash flow by year

2016 → 2025

FY 2016$-22.4MFY 2017$-31.0MFY 2018$-13.4MFY 2019$-28.0MFY 2020$-28.5MFY 2021$-23.0MFY 2022$-35.0MFY 2023$-36.1MFY 2024$49.5MFY 2025$31.3M
-$22.4M$31.3M

Gross margin by year

2021 → 2025

FY 202188.7%FY 202287.0%FY 202394.0%FY 202471.5%FY 202587.3%
88.7%87.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

7

Insider sells · 90 days

Earnings

Last reported: May 18, 2026 (EPS $-0.08)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Annual reportAnnual Report FiledMay 18, 2026Filing
  • Insider sellInsider Sell $16K · 10b5-1 PlanOphir Eran · Director, President and CEO · $16KApr 27, 2026Filing
  • Insider sellInsider Sell $6K · 10b5-1 PlanLevine Zurit · SVP, Business Development · $6.4KApr 27, 2026Filing
  • Insider sellInsider Sell $8K · 10b5-1 PlanLevine Zurit · SVP, Business Development · $8KApr 15, 2026Filing
  • Insider sellInsider Sell $6K · 10b5-1 PlanLevine Zurit · SVP, Business Development · $5.6KApr 15, 2026Filing
  • Insider sellInsider Sell $15K · 10b5-1 PlanOphir Eran · Director, President and CEO · $14.5KApr 15, 2026Filing
  • Insider sellInsider Sell $8K · 10b5-1 PlanLevine Zurit · SVP, Business Development · $8KApr 13, 2026Filing
  • Insider sellInsider Sell $19K · 10b5-1 PlanLevine Zurit · SVP, Business Development · $18.8KApr 9, 2026Filing
  • Insider sellInsider Sell $12K · 10b5-1 PlanOphir Eran · Director, President and CEO · $12.4KApr 3, 2026Filing
  • Insider sellInsider Sell $8K · 10b5-1 PlanLevine Zurit · SVP, Business Development · $7.7KApr 3, 2026Filing

Questions

Frequently asked questions

What is Compugen Ltd.'s market cap?

Compugen Ltd. (CGEN) has a market capitalization of $254.8M.

What is CGEN's P/E ratio?

CGEN trades at a price-to-earnings ratio of 7.0, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is CGEN's price-to-book (P/B) ratio?

CGEN trades at 2.48 times book value per share.

When did Compugen Ltd. last report earnings?

CGEN last reported earnings on May 18, 2026; the next date is not yet scheduled.

Are insiders buying CGEN stock?

SEC Form 4 filings show no open-market insider buys at Compugen Ltd. in the last 90 days (7 sells).

Same arena

Related companies in Biotechnology

FHTX

Foghorn Therapeutics Inc.

$253.6M

CDXS

Codexis, Inc.

$258.1M

STRO

Sutro Biopharma, Inc.

$251.1M

IVA

Inventiva S.A.

$259.9M

LENZ

LENZ Therapeutics, Inc.

$249.3M

ALEC

Alector, Inc.

$242.6M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.